Van Eck Associates Corp Dexcom Inc Transaction History

Van Eck Associates Corp

$108 Billion
Q3 2025

A detailed history of Van Eck Associates Corp transactions in Dexcom Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 77,128 shares of DXCM stock, worth $4.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,128

Previous 83,074 7.16%

Holding current value

$4.48 Million

Previous $7.25 Million 28.43%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$66.46 - $89.53 $395,171 - $532,345	-5,946 Reduced 7.16%	77,128 $5.19 Million
Q2 2025 Aug 14, 2025	SELL	$59.83 - $87.57 $178,951 - $261,921	-2,991 Reduced 3.48%	83,074 $7.25 Million
Q1 2025 May 15, 2025	BUY	$67.74 - $90.75 $17,070 - $22,869	252 Added 0.29%	86,065 $5.88 Million
Q4 2024 Jan 29, 2025	BUY	$65.68 - $81.01 $4.31 Million - $5.32 Million	65,622 Added 325.01%	85,813 $6.67 Million
Q3 2024 Oct 29, 2024	BUY	$64.0 - $116.06 $158,400 - $287,248	2,475 Added 13.97%	20,191 $1.46 Million

Q2 2024 Jul 31, 2024	BUY	$110.31 - $140.45 $140,534 - $178,933	1,274 Added 7.75%	17,716 $2.01 Million
Q1 2024 Apr 30, 2024	SELL	$114.22 - $140.1 $173,271 - $212,531	-1,517 Reduced 8.45%	16,442 $2.28 Million
Q4 2023 Feb 05, 2024	SELL	$75.49 - $124.16 $201,860 - $332,003	-2,674 Reduced 12.96%	17,959 $2.23 Million
Q3 2023 Nov 08, 2023	BUY	$86.06 - $137.93 $161,534 - $258,894	1,877 Added 10.01%	20,633 $1.93 Million
Q2 2023 Aug 03, 2023	SELL	$112.47 - $130.98 $134,851 - $157,045	-1,199 Reduced 6.01%	18,756 $2.41 Million
Q1 2023 May 03, 2023	BUY	$104.0 - $122.92 $969,904 - $1.15 Million	9,326 Added 87.74%	19,955 $2.32 Million
Q4 2022 Feb 08, 2023	BUY	$84.98 - $122.67 $372,637 - $537,907	4,385 Added 70.23%	10,629 $1.2 Million
Q3 2022 Oct 27, 2022	BUY	$76.35 - $94.18 $476,729 - $588,059	6,244 New	6,244 $503,000
Q1 2022 May 10, 2022	SELL	$94.08 - $130.2 $28,976 - $40,101	-308 Closed	0 $0
Q4 2021 Jan 26, 2022	BUY	$129.87 - $162.82 $39,999 - $50,148	308 New	308 $165,000
Q1 2021 May 13, 2021	SELL	$84.79 - $104.74 $112,007 - $138,361	-1,321 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$78.0 - $104.5 $68,718 - $92,064	881 Added 200.23%	1,321 $488,000
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $42,024 - $49,698	440 New	440 $181,000

Others Institutions Holding DXCM

# of Institutions

1,085

Shares Held

376M

Call Options Held

6.76M

Put Options Held

7.24M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Dexcom Inc Transaction History